ArticleFrontiers in cardiovascular medicine2026
Comparison of the triglyceride/high-density lipoprotein ratio, lipid profile, and glycated hemoglobin and their association with coronary artery disease in the older adult Saudi population: a case-control study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: There is a lack of information regarding ethnic variability in the association between the triglyceride/high-density lipoprotein (TG/HDL) ratio and coronary artery disease (CAD), particularly in the Saudi population. This study aimed to evaluate the association, sensitivity, and specificity of TG/HDL ratio in relation to CAD in the Saudi population. Methods: This study is a retrospective, analytical case-control study. Data were obtained from patients' electronic medical records at King Saud University Medical City (KSUMC) between 2015 and 2023. The vessel scores and Gensini score were used to assess the extent of vessel involvement and the severity of coronary occlusion. Participants were divided into two groups: (1) a healthy control group with no CAD and aged over 50 years, and (2) patients with CAD aged over 50 years. Patients with CAD underwent selective coronary angiography according to the hospital's routine procedures. Biochemical markers were measured at the time of coronary angiography. Results: Multivariable logistic regression model showed that TG/HDL ratio was significantly associated with CAD (OR = 1.87, 95% CI [1.35, 2.58], Conclusion: The TG/HDL ratio was significantly associated with the occurrence of CAD in Saudi population aged over 50 years. However, it was less sensitive and specific than HDL and HbA1c as biomarkers for detecting CAD. Overall, these findings indicate that HbA1c is the most powerful biomarker for predicting CAD among adults aged ≥ 50 years.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.